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we recently reported that a com-plex between focal adhesion 
kianse (faK) and the molecular scaf-
fold racK1 controlled nascent integrin 
adhesion formation and cell polarization, 
via peripheral recruitment of the camp-
degrading pdE4d5 isoform. here we 
review and extend these studies by 
demonstrating that the faK/racK1/
pdE4d5 ‘direction-sensing’ complex 
likely functions by signaling, via the 
guanine nucleotide exchange factor 
Epac, to its small Gtpase target rap1. 
specifically, activating Epac suppresses 
polarization of squamous cancer cells, 
while, in contrast, modulating pKa, 
the other major camp effector, has no 
effect. moreover, faK-deficient malig-
nant keratinocytes re-expressing a faK 
mutant that cannot bind to racK1, 
namely faK-E139a,d140a, display 
elevated rap1 that is linked to impaired 
polarization. thus, it is likely that the 
faK/racK1/pdE4d5 complex signals 
to keep rap1 low at appropriate times 
and in a spatially-regulated manner as 
cells first sense their environment and 
make decisions about nascent adhesion 
stabilization and polarization. racK1 is 
abundantly expressed in both normal and 
malignant keratinocytes, while faK and 
pdE4d5 are both elevated in the cancer 
cells, suggesting that the faK/racK1/
pdE4d5/rap1 signaling axis may con-
tribute to faK’s well documented role in 
tumor progression.
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Cell Polarization and Nascent  
Adhesion Structures: RACK1
Cell polarization requires the differential 
localization of specific protein complexes 
within cells, as well as the correct spa-
tial distribution of structures like Golgi 
and the microtubule-organizing center. 
Understanding the signals that regulate 
spatial events is important, since polar-
ization and directional migration are key 
to many physiological processes such as 
embryonic development, inflammatory 
responses, wound healing and during can-
cer cell invasion. Although important for 
directional migration, the mechanisms 
underlying assembly and spatial distribu-
tion of signaling complexes as cells first 
contact ECM remain to be fully defined. 
Previous studies have identified protein 
complexes that regulate polarization in a 
number of contexts. For example, integ-
rin-induced activation of Cdc42 controls 
the ability of astrocytes to polarize in 
response to a wound made in a confluent 
cell monolayer, by leading to the activa-
tion and recruitment of the mPar6/PKC 
complex.1,2
Cell polarization and directional 
migration also require the coordinated 
and dynamic regulation of the actin 
cytoskeleton, critically at structures close 
to the protruding edge and cell-substra-
tum interface as cells move forward. 
Mass spectrometry studies have identi-
fied proteins that can bind transiently to 
focal adhesion components, and demon-
strated the existence of nascent adhesion 
structures, originally called Spreading 
Initiation Centers (SICs). These are actin-
based structures that form transiently as 
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of an effecter mutant of FAK, namely 
FAK-E139A,D140A, results in profound 
changes in cellular morphology remi-
niscent of non-polarized cells that lack 
cytoplasmic actin filaments (fig. 1b and 
reviewed in ref. 4). Moreover, RACK1 
localization is restricted to the cytoplasm 
and the FAK-E139A,D140A-expressing 
cells are unable to efficiently form nascent 
adhesion structures when compared 
to FAK-wt-expressing SCC cells (fig. 
1c; solid arrows point to nascent adhe-
sions in FAK-wt cells and broken arrows 
point to cytoplasmic RACK1 in FAK-
E139A,D140A cells). These data indicate 
that the FAK/RACK1 complex is spa-
tially regulated at nascent adhesions.
FAK/RACK1:  
A “Direction-Sensing Complex”
While typical apical-basolateral epithe-
lial polarity is frequently lost in cancer 
cells, polarization and directional migra-
tion towards extracellular stimuli (and 
perhaps host cells) likely plays a role in 
cancer invasion and metastatic spread. 
However, little is known about protein 
complexes specifically involved in direc-
tion-sensing and how invasive cancer 
cells turn and polarize, towards extra-
cellular stimuli. We found a role for the 
FAK/RACK1 complex in cell invasion 
and wound induced cell polarity. In par-
ticular, FAK is needed for wound-induced 
polarization of SCC cells and chemotac-
tic invasion through 3D matrix gels.4 We 
believe this represents a novel “direction-
sensing complex” that is essential for the 
formation of nascent adhesion structures 
which permit cells to sense and polarize 
towards chemotactic factors. As the FAK/
RACK1 complex was also evident in fully 
spread cells, we used time-lapse micros-
copy to monitor RACK1 position in live 
cells. This demonstrated that cells are 
constantly generating RACK1 containing 
membrane “blebs”, which can stabilize 
and these transient structures presumably 
act as environmental sensors; the pat-
tern of their stabilization and turnover, 
i.e., their dynamic regulation controls 
cell polarization and migration in 
response to directional cues (Movies 
can be viewed in Sup. Information 
in ref. 4).
and the other within its conserved cata-
lytic unit.22,23 A number of these RACK1 
protein interactions influence integ-
rin function, and integrin-dependent 
cell migration and chemotaxis.13,15,16 
RACK1 binds to the integrin effector 
protein Focal Adhesion Kinase (FAK) 
and RACK1 tyrosine phosphorylation by 
c-Abl is proposed to mediate insulin-like 
growth factor1-dependent regulation of 
FAK.24
FAK is present and co-localizes with 
RACK1, at nascent protrusive structures 
that form as Mouse Embryo Fibroblasts 
(MEFs) spread on ECM components.4,25 
FAK is a pivotal signal integrator operating 
at focal adhesions (its biological functions 
are depicted in fig. 1a) and is required for 
cell spreading, optimal integrin-depen-
dent cell migration and integrin-induced 
signaling that promotes proliferation 
and survival.26-32 FAK’s role in assembly 
of actin-based structures that mediates 
cell spreading includes the binding and 
regulation of the Arp2/3 actin nucleation 
complex.25 Nascent lamellipodia, which 
originate at the tips of SICs, do not form 
in FAK-deficient cells or in cells in which 
FAK cannot be tyrosine phosphorylated 
after integrin engagement.4,25 Thus, FAK 
links integrin signaling directly to the 
actin assembly machinery, and we have 
implicated the FAK FERM domain in 
this process.4,25
In more recent work, we identified 
that the FAK FERM domain, specifi-
cally residues E139 and D140, which is 
required for direct binding of FAK to 
RACK1. Unlike the previously identified 
complex between FAK and Arp3, where 
binding is regulated by integrin induced 
FAK-Y397 phosphorylation, the FAK/
RACK1 complex does not change under 
these conditions. Using Squamous Cell 
Carcinoma (SCC) cells, in which FAK 
could be genetically deleted by tamoxi-
fen treatment, we found that FAK is 
required for both cell spreading and 
RACK1 localization to nascent adhesions 
close to the cell-substratum interface 
as imaged by Total Internal Reflection 
Fluorescence microscopy (TIRF).4 Small 
patches of FAK/RACK1 co-localization 
are also evident at nascent adhesive struc-
tures in fully spread cells. Disruption 
of this interaction through expression 
cells first make contact locally with the 
ExtraCellular Matrix (ECM; reviewed in 
ref. 3). Exaggerated versions of SICs form 
in close proximity to the cell-substratum 
interface as suspended cells are plated 
onto ECM, and so first make contact with 
ECM components. Therefore, SICs prob-
ably represent nascent or ‘first point of 
contact’, structures that assemble and dis-
assemble rapidly as cells adhere and move 
around on ECM components. SICs have 
been described to contain ribosomal RNA 
and RNA-binding proteins, which con-
tribute to cell spreading3 and are clearly 
distinct from mature focal adhesions. In 
our recent work, we described nascent 
adhesive structures that may be similar to 
the previously described SICs, and these 
are distinguished from other focal adhe-
sion structures by containing the signal-
ing scaffold protein Receptor for Activated 
C Kinase 1 (RACK1; reviewed in ref. 4), 
which is not generally found at mature 
adhesions.3,4
RACK1: A Complex with FAK 
Important for Nascent Adhesion 
Assembly
RACK1 is a widely expressed WD-repeat 
protein that was originally identified as a 
protein that could bind phorbol ester-acti-
vated PKC isoforms, notably PKCbII.5-8 
However, RACK1 is now known to regu-
late diverse cellular processes such as pro-
tein translation, cytokinesis, cell adhesion 
and migration. RACK1 is a multi-func-
tional scaffold protein that binds to a wide 
variety of proteins, impacting on multiple 
signal transduction pathways via com-
partmentalization, so bringing together 
key signaling components in time and 
space.8-10 Amongst the increasing reper-
toire of RACK1 binding partners are Src 
and Abl tyrosine kinases,11,12 β1-integrin 
cytoplasmic domains,13 the p85 regula-
tory sub-unit of PI 3-kinase,14 a number 
of protein tyrosine phosphatases, includ-
ing PTP1B13,15-17 and PTPmu,17 PLCγ,18 
dynamin,10 p120Ras-GAP,19 HIF1α20 
and others (reviewed in ref. 8 and 21). 
Notable amongst RACK1 binding part-
ners is the cAMP-degrading phosphodies-
terase PDE4D5, which binds to RACK1 
via two well-defined sites, one within its 
isoform-specific amino-terminal region 
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cells.4 Moreover, a complex exists con-
taining FAK, RACK1 and PDE4D5 that 
requires FAK’s association with RACK1 
and RACK1’s association with PDE4D5, 
and this complex is necessary for nascent 
adhesion stabilization and wound-induced 
polarization.4 Our work showed that when 
the FAK-RACK1 complex is perturbed, 
neither RACK1 nor PDE4D5 can local-
ize to nascent protrusions or to the lead-
ing edge of wounded cells. However, the 
by FAK-bound RACK1 to nascent adhe-
sions, and found a key role for the RACK1 
cargo—a particular PDE4 family iso-
form, namely PDE4D5,23 known to bind 
to RACK1 through a well-characterized 
interaction involving its isoform specific 
N-terminal region.33,34 Inhibition of the 
FAK/RACK1 complex blocked the co-
recruitment of RACK1 and PDE4D5 to 
nascent adhesions (also shown here in fig. 
1c) and to the leading edge of polarizing 
How does FAK/RACK1 Complex 
Control Direction-Sensing?:  
Recruitment of PDE4D5
A key question was why inhibiting FAK 
binding to the enzymatically-inert scaf-
fold protein RACK1 blocked stabilization 
of transient nascent adhesion structures 
and caused profound direction sensing 
and polarization defects. We addressed the 
nature of the sequestered cargo delivered 
Figure 1. (a) Schematic showing the recognized cellular functions of FaK, highlighting the direction-sensing and polarization functions we describe 
here. (B) images show comparison of cell shape and actin filaments in FaK-deficient SCC cells re-expressing either FaK-wt or the FaK/raCK1 binding 
impaired mutant FaK-E139a,D140a. (C) The co-staining of raCK1 and PDE4D5 is shown in protrusive nascent adhesions as FaK-wt SCC cells are plated 
on to FN for 15 min (solid arrows). By comparison, both raCK1 and PDE4D5 are cytoplasmic in FaK-E139a,D140a-expressing cells (broken arrows). Scale 
bars 20 μm.
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complex. Indeed, both FAK and RACK1 
are molecular scaffolds that can bind inde-
pendently to a wide range of intracellular 
proteins, yet these two scaffold proteins 
also bind to each other, with FAK dictat-
ing the spatial distribution of RACK1 and 
one of its clients, PDE4D5. The assem-
bly of this complex presumably regulates 
local gradients of cAMP. Here we show 
that this likely regulates EPAC-dependent 
activation of the small GTPase Rap1. 
This new work ‘joins up’ a line of research 
articles that show the EPAC-Rap1 signal-
ing axis has an important role in integrin 
adhesion dynamics, migration and polar-
ity.35-37 We interpret our results and these 
previous findings to imply that Rap1’s role 
in cell polarization requires both GTPase 
activation and inactivation to be tightly 
regulated in space and time, and that the 
FAK/RACK1/PDE4D5 complex serves to 
keep Rap1 transiently inactive at appropri-
ate times in the vicinity of nascent adhe-
sions as they form and stabilize. The FAK 
mutant protein that would result in an 
inability to depress Rap1 activity in the 
vicinity of nascent adhesions as they form 
causes lack of stabilization (depicted in 
model in fig. 3a).
The spatially determined FAK/RACK/
PDE4D5-EPAC/Rap1 signaling axis may 
well contribute to FAK’s role in promot-
ing the invasive cancer phenotype, that we 
showed previously by tissue-specific FAK 
deletion studies in skin and breast can-
cer models.38,39 Several studies have also 
implicated release of cAMP gating, PDE 
enzymes and PDE4 in particular, in cancer 
cell invasion and migration of a number of 
cell types.40-42 Hence the direction-sensing 
FAK/RACK1/PDE4D5 complex, via sig-
naling to EPAC and Rap1 in space and 
time, is a likely contributor to the inva-
sive cancer phenotype. In this regard, we 
note that while RACK1 is abundantly 
and equivalently expressed in both murine 
normal and malignant keratinocytes (SCC 
cells) (fig. 3b), both FAK and PDE4D5 
are elevated in SCC cells, showing that the 
pathway potential is elevated during pro-
gression to the malignant phenotype.
Methods
materials. Antibodies for immunoblot-
ting and immunocytochemistry were 
2b). Thus, it appears that elevated cAMP 
exerts its inhibitory effect on polarization 
through an action mediated by EPAC, 
rather than by PKA.
RACK1 Mediates Signaling from 
FAK to the Small GTPase Rap1
EPAC exerts actions via its role as a gua-
nine-nucleotide exchange factor for the 
Rap small GTP binding proteins.35 We 
found that challenge of FAK-wt cells with 
CPT-cAMP (the EPAC agonist) increased 
Rap1 activation, as judged by increased 
GTP loading, providing evidence that 
CPT-cAMP does indeed activate EPAC 
in these SCC cells (fig. 2c, right part). 
Importantly, we also found that the activ-
ity of Rap1 in FAK-E139A,D140A cells 
was increased when compared to FAK-wt 
cells (fig. 2c, left part), while there was 
no change in Cdc42 activity that is often 
associated with polarity (not shown). 
Quantification shown is a combination of 
multiple experiments and demonstrated a 
consistent 1.8 fold increase in Rap1 activ-
ity in FAK-E139A,D140A cells vs. FAK-wt 
cells. As this FAK-E139A,D140A mutant 
fails to sequester the PDE4D5/RACK1 
complex and stabilize nascent adhesions 
(or SICs) during cell spreading, our data 
imply that in cells expressing this FAK/
RACK1 binding-impaired FAK mutant 
protein—cAMP levels to rise unchecked 
in the vicinity of FAK at the periphery of 
cells as they sense their environment. In 
this way, EPAC and its downstream tar-
get Rap1, would become constitutively 
activated. This uncontrolled activity of 
EPAC/Rap1 is linked to the loss of abil-
ity to stabilize nascent adhesive structures, 
and consequentially impaired cell spread-
ing and responses to directional cues that 
are needed for cells to polarize.
Final Thought
Thus, we previously defined a novel “direc-
tion sensing complex” that comprises 
of FAK, RACK1 and PDE4D5. This is 
needed for cells to stabilize nascent actin-
based adhesive structures and to polarize 
in response to directional cues. This work 
identified a new function for the FAK 
FERM domain, and a physiological func-
tion for the enigmatic RACK1-PDE4D5 
question remained as to the nature of 
PDE4D5-induced or suppressed, signals 
that are permissive for stabilization of 
nascent adhesion, cell polarization and 
directional migration.
FAK/RACK1/PDE4D5:  
Signaling via PKA or EPAC?
It is now well established that cAMP sig-
naling is compartmentalized in cells with 
gradients of cAMP interpreted by seques-
tered populations of the two cAMP effec-
tors, Protein Kinase A (PKA) and EPAC.34 
Sub-populations of spatially constrained 
PDEs form and shape these gradients at 
defined locales, thereby determining the 
activation threshold for specific signaling 
complexes that incorporate either or both, 
PKA and EPAC.34 The role of EPAC can 
usefully be inferred by using the selec-
tive EPAC agonist, 8-CPT-2OMe-cAMP 
(CPT-cAMP), which is unable to activate 
PKA.35 We found that CPT-cAMP treat-
ment of FAK-wt cells elicited a profound 
loss of wound-induced polarization (~71% 
to ~31%), similar to the polarization dis-
played by FAK-deficient cells (~27%, data 
not shown) or in cells where FAK and 
RACK1 can no longer interact (~28%) 
(FAK-E139A,D140A termed E139 in fig. 
2a), suggesting that the cAMP polariza-
tion phentotype regulated by the FAK/
RACK1/PDE4D5 complex may be deter-
mined by the action of EPAC rather than 
PKA (fig. 2a). We also noted that CPT-
cAMP did not induce any further loss of 
polarization in FAK-E139 cells, implying 
the FAK/RACK1 disrupting mutation 
and CPT-cAMP influence the same sig-
naling effector, namely EPAC. Consistent 
with this, we now report that the selec-
tive PKA agonist, N6-Bnz-cAMP,35 had 
no effect on polarization, even although 
it visibly induced phosphorylation of the 
transcription factor substrate of PKA, i.e., 
CREB (cAMP-regulatory binding pro-
tein; fig. 2b, right part). Furthermore, 
loss of polarization in cells challenged 
with the cAMP analogue, 8-Brm-cAMP, 
which can activate both EPAC and 
PKA, was not attenuated by the selective 
PKA inhibitor, KT5720 (fig. 2a). This 
occurred under circumstances where the 
PKA-mediated phosphorylation of CREB 
was clearly inhibited by KT5720 (fig. 
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(OH)-tamoxifen at a concentration of 10 
μM for 24 hours. FAK-deficient (-/-) SCC 
cells expressing FAK mutants (wt or FAK-
E139A,D140A) were generated by amaxa 
nucleofection kit v, programme P20, using 
the pWZL-FAK expression constructs 
outlined before.4
immunocytochemistry and cell polar-
ization assays. For immunocytochemistry, 
cells were grown on glass coverslips, rinsed 
in TBS, fixed in 3.7% formaldehyde-PBS, 
100 mM K-Pipes pH 6.8, 10 mM EGTA, 
(FN) and reduced growth factor Matrigel 
were obtained from Becton Dickinson, 
(354230). Triton X100, TRITC-
phalloidin and 4-OHT were obtained 
from Sigma.
Generation of faK-deficient scc cell 
lines. K14CreERT2/FAKflox/flox mice were 
subjected to chemical carcinogenesis and 
cells generated as described previously in 
reference 4. The cells were harvested by 
trypsinization and subcultured. To delete 
fak, cells were treated with 4-hydroxy 
as follows: anti-FAK (Transduction 
Laboratories, 610088); anti-actin (Sigma, 
A4700); anti-pCREB (Cell Signaling 
Technology, 9196); and anti-PDE4D5 
(described previously in ref. 4). Anti-
mouse and anti-rabbit IgG-peroxidase 
conjugated secondary antibodies were 
from New England Biolabs (7076, 7074), 
anti-sheep IgG-peroxidase conjugated 
secondary antibodies were obtained from 
Invitrogen and TRITC-phalloidin was 
obtained from Sigma. Human fibronectin 
Figure 2. (a) FaK-wt or FaK-E139a,D140a cells (as indicated) were plated on FN for 2 hours and wounded in the presence of 8-CPT-2OMe caMP (CPT-
caMP; 10 μM), KT 5720 (1 μM), 8-Brm-caMP (10 μM), KT 5720 + 8-Brm-caMP or N6-Bnz-caMP (10 μM). after 1.5 hours cells were fixed and stained with 
the Golgi marker anti-GM130, TriTC phalloidin and DaPi, to assess polarization in response to the wounded areas. The percentage of each cell type 
with the Golgi orientated to the wound was calculated by counting 100 cells in 3 experiments and is shown in the graph. (B) FaK-wt cells were treated 
with KT 5720 (1 μM) and/or N8 = Brm-caMP (left parts) and with 6-Bnz-caMP (10 μM) for 30 min then immunoblotted using anti-phospho-CrEB and 
actin antibodies as probes. (C) FaK-wt cells with or without CPT-caMP (10 μM for 3.5 hrs, time point chosen to maintain consistency with cell polariza-
tion experiments, conditions detailed above; left part) or FaK-wt and FaK-E139a,D140a cells (right part), were harvested and a rap1 assay performed 
as described in Materials and Methods. Quantification of rap1-GTP normalized to total rap1 from three separate experiments is shown.
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Figure 3. (a) Model outlining how our data explains the role of the FaK/raCK1/PDE4D5 complex in keeping caMP levels low in the vicinity of nascent 
peripheral adhesion structures as these form and sense their environment. in our model, this is required for a sub-set of nascent adhesions to stabilize, 
typically along one cell edge, so inducing a polarized phenotype. The FaK/raCK1-mediated recruitment of PDE4D5 signals to rap1, likely via EPaC, 
to keep rap1 appropriately suppressed in space and time so as to permit nascent adhesion stabilization, spreading and polaization. This is in keeping 
with our earlier data recently published in reference 4. The edges of cells expressing FaK-wt (top images showing stabilized protrusive structures) and 
FaK-E139a,D140a (lower images) are shown, including TirF images (black and white) taken at the cell-substratum interface. (B) Expression levels of 
FaK, raCK1 and PDE4D5 were determined in lysates from normal and malignant keratinocytes (SCCs) which were immunoblotted using anti-FaK, anti-
raCK1, anti-PD4D5 and anti-actin antibodies as probes.
60 Small GTPases volume 2 issue 1
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